Download PDFPDF
Diagnosis and management of adult onset Still’s disease
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Lia T. Umikashvili
    Published on:
  • Published on:
    Thank you

    Dear Editor, this is the most up-to-dated, complete, holistic and informative article on AOSD existed contemporaneously.

    My only addition/suggestion would be to indicate suggested average duration of treatment (for steroids and immunosuppressive drugs) when symptoms are controlled. What it should be an average duration of giving for example methotrexate or plaqueline when laboratory tests are within the norm, symptoms...

    Show More
    Conflict of Interest:
    None declared.